The review asserts that balanced intake of macronutrients and micronutrients (vitamins A, D, E, B-complex, C; minerals Se, Zn, Fe, Cu, Cr, Mg) supports innate and adaptive immunity, and catalogues dietary sources, milk components, and functional foods with purported immunomodulatory effects.
The general direction of the review is consistent with higher-quality literature: vitamin D insufficiency correlates with impaired TLR7 expression and cathelicidin production in aged cohorts (r = -0.340 for 25OHD vs age, p<0.007), and vitamin E 200 mg/day for 3 months improved neutrophil/lymphocyte function in 33 elderly subjects. However, the review's mechanism-level claims (e.g., 'water before sleep reduces heart attack risk', unqualified benefits of volatile oils) are presented without dosing, uncertainty, or conflict-of-interest scrutiny that companion reviews applied — e.g., the vitamin C/zinc literature itself notes sponsor influence (Bayer funding) and mixed clinical outcomes. The review also omits the key nuance that high-dose supplementation can be null or adverse in replete adults.
Quantitative evidence the review does not engage with: in heat-stressed broilers, secondary IgG responses rose from 3.2 (750 IU/kg vitamin A) to ~5.0 (1500–15000 IU/kg), illustrating dose-response immune effects in animal models that the review's flat 'vitamin A enhances immunity' framing glosses over.
Key missing elements: no PRISMA-style methodology, no effect sizes or confidence intervals, conflation of animal and human data, no dose-toxicity discussion, and no acknowledgment that deficiency-correction (not supraphysiological supplementation) drives most documented benefits. Falsifying the review's strongest claims would require showing that correcting specific deficiencies does not restore immune parameters — unlikely — whereas its weaker claims (volatile oils, generic 'superfoods') lack any testable specificity.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.